Total cholesterol and risk of mortality in the oldest old

Lancet

Volumn 350, Issue 9085, 1997, Pages 1119-1123

  Weverling Rijnsburger, Annelies W E ^a   Blauw, Gerard J ^a   Lagaay, A Margot ^a   Knook, Dick L ^a   Meinders, A Edo ^a   Westendorp, Rudi G J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

AGED; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; FEMALE; HUMAN; LONGEVITY; MAJOR CLINICAL STUDY; MALE; MODEL; MORTALITY; PRIORITY JOURNAL;

EID: 0030699431     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)04430-9     Document Type: Article

References (27)

1. Jacobs D, Blackburn H, Higgins M, et al. Report of the conference on low blood cholesterol: mortality associations. Circulation 1992; 86: 1046-60.
2. Muldoon MF, Manuck SB, Matthews KA. Lowering cholesterol concentrations and mortality: a quantative review of primary prevention trials. BMJ 1990; 301: 309-14.
3. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335: 1001-09.
4. Lagaay AM, Asperen van IA, Hijmans W. The prevalence of morbidity in the oldest old, age 85 and over: a population-based survey in Leiden, the Netherlands. Arch Gerontol Geriatr 1992; 15: 115-31.
5. Izaks GJ, Houwelingen Van HC, Schreuder GMT, Ligthart GJ. The association between human leucocyte antigens (HLA) and mortality in community residents aged 85 and over. J Am Geriatr Soc 1997; 45: 56-60.
6. Lagaay AM, Meij van der JC, Hijmans W. Validation of medical history taking as part of a population based survey in subjects aged 85 and over. BMJ 1992; 304: 1091-92.
7. WHO. International classification of diseases: manual of the international statistical classification of diseases, injuries, and causes of death. Geneva, Switzerland: WHO, 1977.
8. Pinner RW, Teutsch SM, Simonsen L, et al. Trends in infectious diseases mortality in the United States. JAMA 1996; 275: 189-93.
9. Kromhout D, Bosschieter EB, Drijver M, Lezenne Coulander de C. Serum cholesterol and 25-year incidence of and mortality from infarction and cancer. Arch Intern Med 1988; 148: 1051-55.
10. Vries de CL, Feskens EJM, Lezenne Coulander de C, Kromhout D. Repeated measurements of serum cholesterol and blood pressure in relation to long-term incidence of myocardial infarction. Cardiology 1993; 82: 89-99.
11. Geriatric clinical chemistry reference values. Washington: American Association for Clinical Chemistry Inc, 1994: 312/467.
12. Oldham PD. A note on the analysis of repeated measurements of the same subjects. J Chron Dis 1962; 15: 969-77.
13. Corti MC, Guralnik JM, Salive ME, et al. Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med 1997; 126: 753-60.
14. Krumholz HM, Seeman TE, Merrill SS, et al. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years. JAMA 1994; 272: 1335-40.
15. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality: 30 years of follow-up from the Framingham study. JAMA 1987; 257: 2176-80.
16. Stemmerman GN, Chyou P, Kagan A. Serum cholesterol and mortality among Japanese-American men: the Honolulu (Hawaii) heart program. Arch Intern Med 1991; 151: 969-72.
17. Schuit AJ, Dijk Van CEMJ, Dekker JM, Schouten EG, Kok FJ. Inverse association between serum cholesterol and cancer mortality in Dutch civil servants. Am J Epidemiol 1993; 137: 966-76.
18. Schatzkin A, Hoover NR, Taylor PR, et al. Site-specific analysis of total serum cholesterol and incident cancer in the National Health and Nutrition Examination Survey I: Epidemiological Follow-up Study. Cancer Res 1988; 48: 452-58.
19. Sharp SJ, Pocock SJ. Time trends in serum cholesterol before cancer death. Epidemiology 1997; 8: 132-36.
20. Zureik M, Courbon D, Ducimetière P. Decline in serum total cholesterol and the risk of death from cancer. Epidemiology 1997; 8: 137-43.
21. Delgado-Rodriguez M, Medina-Caudros M, Martinez-Gallego G, Sillero-Arenas M. Total cholesterol, HDL-cholesterol, and the risk of nosocomial infection: a prospective study in surgical patients. Infect Control Hosp Epidemiol 1997; 18: 9-18.
22. Netea MG, Demacker PNM, Kullberg BJ, et al. Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections. J Clin Invest 1996; 97: 1366-72.
23. Katznelson S, Wilkinson AH, Kobashigawa JA, et al. The effect of pravastin on acute rejection after kidney transplantation: a pilot study. Transplantation 1996; 61: 1469-74.
24. Kobashigawa JA, Katnelson S, Laks H, et al. Effect of pravastin on outcomes after cardiac transplantation. N Engl J Med 1995; 333: 621-27.
25. Prospective studies collaboration. Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts. Lancet 1995; 333: 1301-07.
26. Blauw GJ, Lagaay AM, Smelt AHM, Westendorp RGJ. Stroke, statins, and cholesterol: a meta-analysis of randomized placebo controlled blind trials with HMG-Co-A-reductase inhibitors. Stroke 1997; 28: 946-50.
27. Grouse III JR, Byington RP, Hoen HM, Furberg CD. Reductase inhibitor monotherapy and stroke prevention. Arch Intern Med 1997; 157: 1305-10.